Arcoma AB Share Price Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
04-25 | Arcoma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
01-29 | Arcoma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 183M 17.35M 0 1.36B | Sales 2025 * | 199M 18.87M 0 1.48B | Capitalization | 204M 19.37M 0 1.52B |
---|---|---|---|---|---|
Net income 2024 * | 14M 1.33M - 104M | Net income 2025 * | 16M 1.52M - 119M | EV / Sales 2024 * | 1.08 x |
Net cash position 2024 * | 7M 664K 0 52.15M | Net cash position 2025 * | 19M 1.8M 0 142M | EV / Sales 2025 * | 0.93 x |
P/E ratio 2024 * |
15
x | P/E ratio 2025 * |
12.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.16% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Dahlberg
DFI | Director of Finance/CFO | 40 | 31/12/21 |
Chief Tech/Sci/R&D Officer | 53 | 31/12/93 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 31/12/21 | |
Director/Board Member | 53 | 28/02/10 | |
Lars Kvarnhem
CHM | Chairman | 52 | 31/12/16 |
1st Jan change | Capi. | |
---|---|---|
-8.01% | 14.26B | |
-47.14% | 2.42B | |
-18.54% | 2.3B | |
-18.09% | 1.36B | |
-.--% | 1.12B | |
+35.48% | 498M | |
+23.72% | 271M | |
-3.05% | 222M | |
+4.44% | 188M |